Pre-made Technetium (99Mtc) Pintumomab benchmark antibody (Radiolabelled antibody, anti-human adenocarcinoma antigen therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-1013

Anti-human adenocarcinoma antigen therapeutic antibody (Pre-made Technetium (99Mtc) Pintumomab biosimilar, Radiolabelled antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Technetium (99mTc) pintumomab (INN) is a mouse monoclonal antibody for the imaging of adenocarcinoma. It is labelled with the radioisotope technetium-99m.[1]

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-1013-1mg 1mg 3090
GMP-Bios-INN-1013-10mg 10mg Inquiry
GMP-Bios-INN-1013-100mg 100mg Inquiry
GMP-Bios-INN-1013-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Pre-Made Technetium (99Mtc) Pintumomab Biosimilar, Radiolabelled Antibody: Anti-Human Adenocarcinoma Antigen therapeutic antibody
INN Name Technetium (99Mtc) Pintumomab
Targethuman adenocarcinoma antigen
FormatRadiolabelled antibody
DerivationMus musculus
Species Reactivityhuman
CH1 IsotypeIgG1 - kappa
VD LCIgG1 - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies0
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0